HealthTree

Your Feed

Filter by

See content from

Back to the latest

ASH 2023: Fighting DLBCL by Attacking the Microenvironment

ASH 2023: Fighting DLBCL by Attacking the Microenvironment image

The ABC's of Giving to DLBCL Research

The ABC's of Giving to DLBCL Research image

Thumbnail for Fighting DLBCL by Attacking the Microenviroment | Leandro Cerchietti, MD | ASH 2023

Playlist: ASH 2023

Fighting DLBCL by Attacking the Microenviroment | Leandro Cerchietti, MD | ASH 2023

Video details & playlist

Thumbnail for Moving Towards Immunotherapy for Newly Diagnosed DLBCL Patients | Paolo Strati, MD | ASH 2023

Playlist: ASH 2023

Moving Towards Immunotherapy for Newly Diagnosed DLBCL Patients | Paolo Strati, MD | ASH 2023

Video details & playlist

My Loved One Has Passed Away. Where Do I Go From Here? image

My Loved One Has Passed Away. Where Do I Go From Here?

02:00PM - 03:00PM EST

Watch Recording

Making The Most of Your Retirement Income

Making The Most of Your Retirement Income image

Caring for the Lymphoma Caregiver

Caring for the Lymphoma Caregiver image

Caring for the DLBCL Caregiver

Caring for the DLBCL Caregiver image

Promising Results For Treating DLBCL With Odronextamab

Promising Results For Treating DLBCL With Odronextamab image

DLBCL Patient Mental Wellness: Radical Acceptance Technique

DLBCL Patient Mental Wellness: Radical Acceptance Technique image

Chemotherapy Treatment And The Use Of Rituximab In DLBCL

Chemotherapy Treatment And The Use Of Rituximab In DLBCL image

Polivy Is A New Line Of Treatment For DLBCL

Polivy Is A New Line Of Treatment For DLBCL image

Preparing for Medicare Advantage Enrollment 2024

Preparing for Medicare Advantage Enrollment 2024 image

MSKCC’s Clinical Trial: Reversing CAR T-cell Exhaustion with Antioxidants

MSKCC’s Clinical Trial: Reversing CAR T-cell Exhaustion with Antioxidants image

What is Chemo Brain?

What is Chemo Brain? image

What is Chemo Brain?

What is Chemo Brain? image

DLBCL Patients - What is CAR T-Cell Therapy?

DLBCL Patients - What is CAR T-Cell Therapy? image

The FDA Approves Columvi For Relapsed/Refractory DLBCL

The FDA Approves Columvi For Relapsed/Refractory DLBCL image

HealthTree Celebrates the Accomplishments of Carl June, Father of CAR-T

HealthTree Celebrates the Accomplishments of Carl June, Father of CAR-T image

HealthTree Foundation Pillar Three: A Powerful Patient Data Portal

HealthTree Foundation Pillar Three: A Powerful Patient Data Portal image

HealthTree Foundation Pillar Three: A Powerful Patient Data Portal

HealthTree Foundation Pillar Three: A Powerful Patient Data Portal image

HealthTree Foundation Pillar Three: A Powerful Patient Data Portal

HealthTree Foundation Pillar Three: A Powerful Patient Data Portal image

HealthTree Foundation Pillar Two: Meaningful Patient to Patient Connections

HealthTree Foundation Pillar Two: Meaningful Patient to Patient Connections image

HealthTree Foundation Pillar Two: Meaningful Patient to Patient Connections

HealthTree Foundation Pillar Two: Meaningful Patient to Patient Connections image

More from HealthTree